<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font26">and </span>
   <span class="font18">[]. </span>
   <span class="font17">patients </span>
   <span class="font16">with </span>
   <span class="font15">respiratory </span>
   <span class="font14">for </span>
   <span class="font14">infections </span>
   <span class="font13">virus </span>
   <span class="font12">are </span>
   <span class="font12">that </span>
   <span class="font12">The </span>
   <span class="font12">infection </span>
   <span class="font12">viral </span>
   <span class="font12">hematological </span>
   <span class="font12">this </span>
   <span class="font12">children </span>
   <span class="font12">most </span>
   <span class="font12">cell </span>
   <span class="font11">have </span>
   <span class="font11">been </span>
   <span class="font11">has </span>
   <span class="font11">clinical </span>
   <span class="font11">{background </span>
   <span class="font11">not </span>
   <span class="font11">risk </span>
   <span class="font11">these </span>
   <span class="font11">viruses </span>
   <span class="font11">â€" </span>
   <span class="font11">HSCT </span>
   <span class="font11">LRTI </span>
   <span class="font11">influenza </span>
   <span class="font11">RSV </span>
   <span class="font11">mortality </span>
   <span class="font11">was </span>
   <span class="font11">incidence </span>
   <span class="font11">pediatric </span>
   <span class="font11">transplant </span>
   <span class="font11">immunocompromised </span>
   <span class="font11">margin </span>
   <span class="font11">from </span>
   <span class="font11">stem </span>
   <span class="font11">{border-style </span>
   <span class="font11">cause </span>
   <span class="font11">hematopoietic </span>
   <span class="font11">progression </span>
   <span class="font11">studies </span>
   <span class="font11">px;} </span>
   <span class="font11">study </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">its </span>
   <span class="font11">related </span>
   <span class="font11">use </span>
   <span class="font10">can </span>
   <span class="font10">between </span>
   <span class="font10">complications </span>
   <span class="font10">hRV </span>
   <span class="font10">treatment </span>
   <span class="font10">Infect </span>
   <span class="font10">antiviral </span>
   <span class="font10">lower </span>
   <span class="font10">patients, </span>
   <span class="font10">URTI </span>
   <span class="font10">acute </span>
   <span class="font10">also </span>
   <span class="font10">associated </span>
   <span class="font10">but </span>
   <span class="font10">common </span>
   <span class="font10">frequently </span>
   <span class="font10">other </span>
   <span class="font10">pneumonia </span>
   <span class="font10">recipients </span>
   <span class="font10">severe </span>
   <span class="font10">showed </span>
   <span class="font10">such </span>
   <span class="font10">therapeutic </span>
   <span class="font10">therapy </span>
   <span class="font10">well </span>
   <span class="font10">ALL </span>
   <span class="font10">disease </span>
   <span class="font10">symptoms </span>
   <span class="font10">syncytial </span>
   <span class="font10">years </span>
   <span class="font10">â€"% </span>
   <span class="font10">PiV </span>
   <span class="font10">Respiratory </span>
   <span class="font10">after </span>
   <span class="font10">among </span>
   <span class="font10">diagnostic </span>
   <span class="font10">high </span>
   <span class="font10">onset </span>
   <span class="font10">preventive </span>
   <span class="font10">tract </span>
   <span class="font10">who </span>
   <span class="font10">cancer </span>
   <span class="font10">diagnosis </span>
   <span class="font10">estimated </span>
   <span class="font10">factors </span>
   <span class="font10">hMPV </span>
   <span class="font10">however, </span>
   <span class="font10">important </span>
   <span class="font10">known </span>
   <span class="font10">leukemia </span>
   <span class="font10">may </span>
   <span class="font10">observed </span>
   <span class="font10">often </span>
   <span class="font10">retrospective </span>
   <span class="font10">ribavirin </span>
   <span class="font10">terms </span>
   <span class="font10">than </span>
   <span class="font10">were </span>
   <span class="font10">within </span>
   <span class="font10">against </span>
   <span class="font10">all </span>
   <span class="font10">available </span>
   <span class="font10">cases </span>
   <span class="font10">conducted </span>
   <span class="font10">currently </span>
   <span class="font10">efficacy </span>
   <span class="font10">hematologic </span>
   <span class="font10">higher </span>
   <span class="font10">impact </span>
   <span class="font10">only </span>
   <span class="font10">px; </span>
   <span class="font10">recommended </span>
   <span class="font10">rhinovirus </span>
   <span class="font10">specific </span>
   <span class="font10">transplantation </span>
   <span class="font10">upper </span>
   <span class="font10">which </span>
   <span class="font10">{font-family </span>
   <span class="font10">Although </span>
   <span class="font10">CMV </span>
   <span class="font10">However, </span>
   <span class="font10">This </span>
   <span class="font10">adult </span>
   <span class="font10">any </span>
   <span class="font10">both </span>
   <span class="font10">does </span>
   <span class="font10">effective </span>
   <span class="font10">epidemiology </span>
   <span class="font10">font-size </span>
   <span class="font10">found </span>
   <span class="font10">general </span>
   <span class="font10">had </span>
   <span class="font10">identified </span>
   <span class="font10">into </span>
   <span class="font10">isolated </span>
   <span class="font10">lack </span>
   <span class="font10">malignancy </span>
   <span class="font10">morbidity </span>
   <span class="font10">patient </span>
   <span class="font10">positive </span>
   <span class="font10">ranges </span>
   <span class="font10">results </span>
   <span class="font10">review </span>
   <span class="font10">significant </span>
   <span class="font10">there </span>
   <span class="font10">undergoing </span>
   <span class="font10">(%) </span>
   <span class="font10">For </span>
   <span class="font10">Influenza </span>
   <span class="font10">[], </span>
   <span class="font10">adults </span>
   <span class="font10">allogeneic </span>
   <span class="font10">article </span>
   <span class="font10">being </span>
   <span class="font10">clear </span>
   <span class="font10">contact </span>
   <span class="font10">days </span>
   <span class="font10">different </span>
   <span class="font10">diseases </span>
   <span class="font10">double; </span>
   <span class="font10">especially </span>
   <span class="font10">family </span>
   <span class="font10">first </span>
   <span class="font10">human </span>
   <span class="font10">immunosuppressed </span>
   <span class="font10">increased </span>
   <span class="font10">infections, </span>
   <span class="font10">infective </span>
   <span class="font10">malignancies </span>
   <span class="font10">management </span>
   <span class="font10">metapneumovirus </span>
   <span class="font10">more </span>
   <span class="font10">need </span>
   <span class="font10">new </span>
   <span class="font10">parainfluenza </span>
   <span class="font10">performed </span>
   <span class="font10">rate </span>
   <span class="font10">role </span>
   <span class="font10">should </span>
   <span class="font10">significantly </span>
   <span class="font10">solid </span>
   <span class="font10">strategies </span>
   <span class="font10">subjects </span>
   <span class="font10">their </span>
   <span class="font10">year </span>
   <span class="font10">Dis </span>
   <span class="font10">Hematological </span>
   <span class="font10">Other </span>
   <span class="font10">Parainfluenza </span>
   <span class="font10">RNA </span>
   <span class="font10">[]; </span>
   <span class="font10">about </span>
   <span class="font10">according </span>
   <span class="font10">aerosol </span>
   <span class="font10">age </span>
   <span class="font10">al. </span>
   <span class="font10">allow </span>
   <span class="font10">although </span>
   <span class="font10">and/or </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cases, </span>
   <span class="font10">caused </span>
   <span class="font10">community-acquired </span>
   <span class="font10">conditions </span>
   <span class="font10">considering </span>
   <span class="font10">coronavirus </span>
   <span class="font10">death </span>
   <span class="font10">detection </span>
   <span class="font10">developing </span>
   <span class="font10">direct </span>
   <span class="font10">early </span>
   <span class="font10">generally </span>
   <span class="font10">genome </span>
   <span class="font10">given </span>
   <span class="font10">greater </span>
   <span class="font10">highlighted </span>
   <span class="font10">increase </span>
   <span class="font10">influenza, </span>
   <span class="font10">involvement </span>
   <span class="font10">low </span>
   <span class="font10">main </span>
   <span class="font10">measures </span>
   <span class="font10">methods </span>
   <span class="font10">myeloma </span>
   <span class="font10">number </span>
   <span class="font10">options </span>
   <span class="font10">out </span>
   <span class="font10">pathogen </span>
   <span class="font10">pathogens </span>
   <span class="font10">population </span>
   <span class="font10">population, </span>
   <span class="font10">prospective </span>
   <span class="font10">reducing </span>
   <span class="font10">relevant </span>
   <span class="font10">represent </span>
   <span class="font10">several </span>
   <span class="font10">severity </span>
   <span class="font10">single-stranded </span>
   <span class="font10">solid; </span>
   <span class="font10">those </span>
   <span class="font10">very </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(.%) </span>
   <span class="font10">(CoV) </span>
   <span class="font10">(Table </span>
   <span class="font10">(hBoV) </span>
   <span class="font10">(range </span>
   <span class="font10">AML </span>
   <span class="font10">According </span>
   <span class="font10">Bocavirus </span>
   <span class="font10">Clin </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">Human </span>
   <span class="font10">Infections </span>
   <span class="font10">LRTI, </span>
   <span class="font10">PCR </span>
   <span class="font10">PiV, </span>
   <span class="font10">RSV, </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">These </span>
   <span class="font10">Virus </span>
   <span class="font10">adenovirus </span>
   <span class="font10">affected </span>
   <span class="font10">agent </span>
   <span class="font10">agents </span>
   <span class="font10">antibody </span>
   <span class="font10">approach </span>
   <span class="font10">around </span>
   <span class="font10">belonging </span>
   <span class="font10">bold </span>
   <span class="font10">carried </span>
   <span class="font10">chemotherapy </span>
   <span class="font10">consensus </span>
   <span class="font10">control </span>
   <span class="font10">could </span>
   <span class="font10">courier; </span>
   <span class="font10">detected </span>
   <span class="font10">developed </span>
   <span class="font10">development </span>
   <span class="font10">died </span>
   <span class="font10">divided </span>
   <span class="font10">drugs </span>
   <span class="font10">em; </span>
   <span class="font10">evaluating </span>
   <span class="font10">frequent </span>
   <span class="font10">fundamental </span>
   <span class="font10">further </span>
   <span class="font10">hAdV </span>
   <span class="font10">hBoV </span>
   <span class="font10">immunocompetent </span>
   <span class="font10">immunoglobulins </span>
   <span class="font10">infection, </span>
   <span class="font10">intravenous </span>
   <span class="font10">limited </span>
   <span class="font10">manifestations </span>
   <span class="font10">mortality, </span>
   <span class="font10">mortality. </span>
   <span class="font10">multiple </span>
   <span class="font10">myeloma, </span>
   <span class="font10">occur </span>
   <span class="font10">one </span>
   <span class="font10">outcomes </span>
   <span class="font10">patients: </span>
   <span class="font10">patients; </span>
   <span class="font10">possible </span>
   <span class="font10">prevent </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">pt;} </span>
   <span class="font10">reach </span>
   <span class="font10">reactivation </span>
   <span class="font10">reduction </span>
   <span class="font10">reported </span>
   <span class="font10">serotypes </span>
   <span class="font10">shown </span>
   <span class="font10">subjects, </span>
   <span class="font10">systematic </span>
   <span class="font10">total </span>
   <span class="font10">two </span>
   <span class="font10">type </span>
   <span class="font10">variability </span>
   <span class="font10">virus, </span>
   <span class="font10">while </span>
  </p>
 </body>
</html>
